Brief: Calliditas Therapeutics Q1 Operating Loss At SEK 180.1 Mln
16/05/2023 06:18
May 16 (Reuters) - Calliditas Therapeutics AB
CALTX.ST :
* Q1 NET SALES AMOUNTED TO SEK 191.4 MILLION
* Q1 OPERATING LOSS AMOUNTED TO SEK 180.1 MILLION
Source text for Eikon: ID:nWkr8zB7FS
Further company coverage: CALTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Calliditas Therapeutics AB
See all newsBrief: Calliditas To Be Delisted From Nasdaq Stockholm
Brief: Calliditas Therapeutics Takes Certain Corporate Actions Following Announcement By Asahi Kasei
Brief: Asahi Kasei Corp: Notice Regarding Results Of Tender Offer For Shares Of Calliditas Therapeutics AB And Transfer Of Subsidiary
Calliditas Therapeutics AB reports results for the quarter ended in January - Earnings Summary
Brief: Calliditas Q2 Sales Beat Expectations